Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of H-cyte, Inc. (MDVX) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of H-cyte, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1591165.
Total stock buying since 2015: $4,150,229.
Total stock sales since 2015: $83,100.
Total stock option exercises since 2015: $592,232.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2022 | 0 | $0 | 0 | $0 | 42,302,361 | $592,232 |
| 2020 | 25,000 | $3,400 | 0 | $0 | 0 | $0 |
| 2019 | 35,000 | $4,375 | 0 | $0 | 0 | $0 |
| 2017 | 865,138 | $941,921 | 70,000 | $83,100 | 0 | $0 |
| 2016 | 1,758,368 | $3,053,999 | 0 | $0 | 0 | $0 |
| 2015 | 114,500 | $146,534 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2022-02 | 0 | $0 | 0 | $0 | 42,302,361 | $592,232 |
| 2020-01 | 25,000 | $3,400 | 0 | $0 | 0 | $0 |
| 2019-12 | 35,000 | $4,375 | 0 | $0 | 0 | $0 |
| 2017-12 | 7,000 | $4,900 | 0 | $0 | 0 | $0 |
| 2017-09 | 0 | $0 | 70,000 | $83,100 | 0 | $0 |
| 2017-08 | 250,000 | $242,500 | 0 | $0 | 0 | $0 |
| 2017-07 | 10,989 | $9,999 | 0 | $0 | 0 | $0 |
| 2017-06 | 85,000 | $78,735 | 0 | $0 | 0 | $0 |
| 2017-04 | 50,000 | $62,500 | 0 | $0 | 0 | $0 |
| 2017-03 | 250,612 | $323,289 | 0 | $0 | 0 | $0 |
| 2017-02 | 211,537 | $219,998 | 0 | $0 | 0 | $0 |
| 2016-12 | 1,714,287 | $3,000,000 | 0 | $0 | 0 | $0 |
| 2016-04 | 44,081 | $53,999 | 0 | $0 | 0 | $0 |
| 2015-12 | 64,500 | $74,584 | 0 | $0 | 0 | $0 |
| 2015-11 | 50,000 | $71,950 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-02-23 | Fwhc Bridge Friends, Llc (10% Owner) | Option Ex | 693,477 | .01 | 9,708 |
| 2022-02-23 | Fwhc Holdings, Llc (10% Owner) | Option Ex | 41,608,884 | .01 | 582,524 |
| 2020-01-17 | Yurkowsky Michael | Buy | 25,000 | .14 | 3,400 |
| 2019-12-16 | Yurkowsky Michael | Buy | 35,000 | .12 | 4,375 |
| 2017-12-15 | Mogford Jon | Buy | 1,000 | .70 | 700 |
| 2017-12-15 | Thomas John C | Buy | 6,000 | .70 | 4,200 |
| 2017-09-19 | Haufe Scott | Sale | 20,000 | 1.18 | 23,600 |
| 2017-09-18 | Haufe Scott | Sale | 50,000 | 1.19 | 59,500 |
| 2017-08-21 | Gorlin Steve | Buy | 50,000 | 1.25 | 62,500 |
| 2017-08-16 | Gorlin Steve | Buy | 200,000 | .90 | 180,000 |
| 2017-07-14 | Betz Randal R | Buy | 10,989 | .91 | 9,999 |
| 2017-06-28 | Gorlin Steve | Buy | 5,000 | .88 | 4,375 |
| 2017-06-19 | Gorlin Jarrett S (CHIEF EXECUTIVE OFFICER) | Buy | 20,000 | .90 | 18,000 |
| 2017-06-14 | Gorlin Steve | Buy | 5,000 | .97 | 4,850 |
| 2017-06-07 | Gorlin Steve | Buy | 30,000 | .96 | 28,710 |
| 2017-06-06 | Gorlin Jarrett S (CHIEF EXECUTIVE OFFICER) | Buy | 25,000 | .91 | 22,800 |
| 2017-04-18 | Haufe Scott | Buy | 50,000 | 1.25 | 62,500 |
| 2017-03-28 | Haufe Scott | Buy | 250,612 | 1.29 | 323,289 |
| 2017-02-09 | Gorlin Jarrett S (CHIEF EXECUTIVE OFFICER) | Buy | 67,307 | 1.04 | 69,999 |
| 2017-02-09 | Gorlin Steve | Buy | 144,230 | 1.04 | 149,999 |
| 2016-12-01 | Gorlin Steve | Buy | 1,142,858 | 1.75 | 2,000,000 |
| 2016-04-19 | Gorlin Jarrett S (CHIEF EXECUTIVE OFFICER) | Buy | 44,081 | 1.23 | 53,999 |
| 2015-12-15 | Kullmann Patrick C (COO, PRESIDENT) | Buy | 4,500 | 1.09 | 4,905 |
| 2015-12-10 | Gorlin Steve | Buy | 20,000 | 1.09 | 21,760 |
| 2015-12-09 | Gorlin Steve | Buy | 20,000 | 1.15 | 22,919 |
| 2015-12-04 | Betz Randal R | Buy | 20,000 | 1.25 | 25,000 |
| 2015-11-24 | Gorlin Steve | Buy | 40,000 | 1.45 | 57,960 |
| 2015-11-23 | Hills Thomas Edward | Buy | 10,000 | 1.40 | 13,990 |
Insider trading activities including stock purchases, stock sales, and option exercises of MDVX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of H-cyte, Inc. (symbol MDVX, CIK number 1591165) see the Securities and Exchange Commission (SEC) website.